Oshi Health vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Oshi Health is a virtual-first gastroenterology care platform providing multidisciplinary treatment for IBS, Crohn's disease, ulcerative colitis, and other GI conditions; raised $60M+ total including a $30M Series B in 2022;
About
Oshi Health is a New York-based digital health company founded in 2018 by Sam Holliday that delivers virtual, multidisciplinary care for chronic digestive and gastrointestinal (GI) conditions. The platform connects patients with an integrated care team — including gastroenterologists, GI-specialized registered dietitians, behavioral health coaches, and care coordinators — to provide comprehensive, ongoing treatment for conditions such as irritable bowel syndrome (IBS), Crohn''s disease, ulcerative colitis, GERD, and functional GI disorders. Care is delivered virtually through telehealth visits, asynchronous messaging, and a patient app that tracks symptoms and supports between-visit adherence.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.